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Marrit Smit1*, Susanne IC Sindram1, Mallory Woiski2, Johanna M Middeldorp1 and Jos van Roosmalen1,3Abstract
Background: At present, there are no guidelines on prevention and management of postpartum haemorrhage in
primary midwifery care in the Netherlands. The first step towards implementing guidelines is the development of a
set of quality indicators for prevention and management of postpartum haemorrhage for primary midwifery
supervised (home) birth in the Netherlands.
Methods: A RAND modified Delphi procedure was applied. This method consists of five steps: (1) composing an
expert panel (2) literature research and collection of possible quality indicators, (3) digital questionnaire, (4)
consensus meeting and (5) critical evaluation. A multidisciplinary expert panel consisting of five midwives, seven
obstetricians and an ambulance paramedic was assembled after applying pre-specified criteria concerning expertise
in various domains relating to primary midwifery care, secondary obstetric care, emergency transportation, maternal
morbidity or mortality audit, quality indicator development or clinical guidelines development and representatives
of professional organisations.
Results: After literature review, 79 recommendations were selected for assessment by the expert panel. After a
digital questionnaire to the expert panel seven indicators were added, resulting in 86 possible indicators. After
excluding 41 indicators that panel members unanimously found invalid, 45 possible indicators were assessed at the
consensus meeting. During critical evaluation 18 potential indicators were found to be overlapping and two were
discarded due to lack of measurability.
Conclusions: A set of 25 quality indicators was considered valid for testing in practice.
Keywords: Quality indicators, Postpartum haemorrhage, Midwifery, Delphi technique, Home birth, The NetherlandsBackground
Postpartum haemorrhage (PPH), internationally defined
as >500 mL of blood loss within 24 hours after child-
birth, remains one of the leading causes of severe mater-
nal morbidity and mortality worldwide, especially in low
resource countries [1].
The definition of PPH, however, is not unified; in
high-resource countries PPH is often defined as blood
loss of at least 1000 mL, while a woman in good health* Correspondence: m.smit.verlos@lumc.nl
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reproduction in any medium, provided the orcan tolerate up to one litre of blood loss without show-
ing early signs of shock [2-6]. Over the last 15 years, an
increase in PPH has been observed in high-resource
countries. The reasons for this remain unclear [7].
Almost one third of Dutch women (32.7%) give birth in
‘primary care’ which is low risk care supervised by a mid-
wife (99% of births) or general practitioner (1% of births).
Of all births in primary care, 64% occur at home [8].
In the Netherlands the overall prevalence of PPH (de-
fined as >1000 mL blood loss), is 5.9%. Of all births in
primary care, 3.4% is complicated with PPH [8]. When
PPH occurs, women are referred to secondary care and
treated by obstetricians. In a home birth setting, womend. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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care provided in case of severe complications in preg-
nancy and childbirth has shown considerable room for
improvement of PPH management [9,10].
The Dutch Society of Obstetrics and Gynaecology
(NVOG) published guidelines concerning prevention
and management of PPH for women giving birth in hos-
pital supervised by an obstetrician [4]. At present, how-
ever, there are no guidelines on prevention and
management of PPH in primary midwifery care in the
Netherlands. Although published obstetrical guidelines
can be and are used in primary midwifery care, the
unique conditions in midwifery care (such as low-risk
profile and birth at home) call for guidelines specifically
designed for primary midwifery care.
The first step towards such guidelines is determining
applicable items, preferably by using quality indicators.
Quality indicators are derived from outcomes of studies,
historical data and expert opinions and are defined as
measurable elements of practice performance for which
evidence or consensus exists. They can be used to assess
and improve quality of care provided to the woman [11].
The aim of this study is to develop a set of quality indi-
cators designed for the prevention and management of
PPH in primary midwifery care.
Methods
The RAND modified Delphi method was used to develop
a set of quality indicators for prevention and management
of PPH in primary midwifery care. This method has been
proved valuable as a systematic method using current sci-
entific evidence in conjunction with expert opinion
[12-15]. For this study, ethical approval was not required.
Indicator development procedure
The procedure for quality indicator development con-
sists of five steps: (1) composing an expert panel, (2) lit-
erature research and collection of recommendations, (3)
questionnaire, (4) consensus meeting and (5), critical
evaluation (Figure 1).
Step 1: composing an expert panel
In order to capture all aspects of care concerning prevention
and management of PPH, members were selected with ex-
pert knowledge in (at least) one of the following domains:
primary midwifery care, secondary obstetric care, emergency
transportation, maternal morbidity or mortality audit, qual-
ity indicator development or clinical guidelines development
and representatives of professional organizations (Royal
Dutch College of Midwives [KNOV] or NVOG).
Step 2: literature research and collection of possible indicators
In order to identify possible indicators for PPH, first
PubMed was searched using the following keywords:‘postpartum haemorrhage’, ‘home birth’, ‘low-risk birth’,
‘prevention’ and ‘third stage of labour’ in combination
with ‘guideline’ or ‘quality indicator’. The Internet was
searched for reports and statements on PPH, especially
in primary (midwifery) care. Following this, international
guidelines, protocols and consensus statements were re-
trieved and collected. Indicators used in secondary ob-
stetric care concerning prevention and management of
PPH were included. Finally, in order to complete the
preliminary set of possible indicators, manuals of obstet-
ric emergency courses regarding prevention and man-
agement of PPH were studied. Due to the lack of a
unified definition of PPH, PPH defined as 500 mL and
1000 mL were categorized separately. Some items, such
as surgical procedures and embolisation, were clearly
not applicable in primary care, and therefore deemed
not relevant for this study.
Other items needed rephrasing for clarification of the
possible indicator. The list of possible indicators was
categorised into five domains: prevention, >500 mL
blood loss <1000 mL, >1000 mL blood loss <2000 mL,
>2000 mL blood loss and organization of care.
Step 3: questionnaire
A questionnaire listing all possible indicators was sent to
all panel members via e-mail. To facilitate decision-
making, the source(s) and relevant literature citations
for each potential indicator were provided.
Panel members were asked to score the possible indi-
cators on a nine-point Likert scale, ranging from ‘one’,
being a poor quality measure of care, to ‘nine’, being an
excellent quality measure. In addition, panel members
had the option of selecting ‘not assessable’. The respon-
dents were asked to score each possible indicator with
respect to their impact on both ‘health gain’ and ‘overall
health efficacy’. Health gain was defined as: ‘An increase
in the health of individuals or population’ and overall
health efficacy was defined as: ‘prevention of unneces-
sary medical treatment and promotion of cost-
effectiveness’ [14]. In addition, panel members were
given the opportunity to provide comments or suggest
additional indicators.
All data were collected and analysed using the Statis-
tical Package for the Social Sciences (SPSS), version 17
(SPSS Inc., Chicago, IL, USA). The median panel rating
and the amount of dispersion of ratings between panel
members were calculated for each potential indicator.
The comments and newly proposed quality indicators
were collected. For an optimal assessment of all possible
indicators offered to the panel, no indicators were
discarded between this questionnaire round and the
consensus meeting. All newly proposed possible indica-
tors were added to the list. Overall agreement on each
item was defined as 75% or more of ratings within a
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Figure 1 The process of quality indicator development according to the RAND-modified Delphi method for prevention and
management of PPH in primary care in the Netherlands.
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(7, 8, and 9). The subsequent consensus meeting focused
on indicators with low agreement.
Step 4: consensus meeting
The expert panel was invited to a face-to-face consensus
meeting. At the onset of the meeting, each panel member
received the list of possible indicators, together with their
own ratings from the questionnaire. The median rating
and the frequency of responses for each possible indicator
were also provided. Finally, panel members received the
list of newly introduced potential indicators from step
three. Individual ratings of the other panel members were
kept confidential. Subsequently, the panel was divided into
three groups of either four or five participants, every
group consisting of at least one midwife and oneobstetrician. Each group was assigned one or two domains
(as described in step two), and were asked to evaluate the
practical applicability of each possible indicator.
Each group (moderated by one of the authors) focused
on indicators not unanimously agreed upon in the first
questionnaire round. Indicators where the range of dis-
agreement was widely spread were also discussed. The
aim was to assess if there was genuine clinical disagree-
ment about the validity of possible indicators or if there
was a problem with phrasing. After the three groups
assessed their assigned domains, the entire panel
discussed potential indicators that were not agreed upon.
After the panel meeting, the members were asked to rate
all the indicators again. The final ratings were analysed
in a similar manner as in step three. Analyses were
performed based on the RAND/UCLA (University of
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An indicator was considered as ‘valid’ if there was an
overall panel median score of eight or higher and if
‘agreement’ was reached between panel members.
Step 5: critical evaluation
In adherence to the RAND method, the core panel crit-
ically evaluated the indicators with high agreement in
step four. Emphasis was put on applicability, feasibility
and measurability. Some indicators were modified or
combined due to overlap between categories or prag-
matic reasons concerning implementation, resulting in a
final consensus-based set of indicators.
Each indicator was assessed and rephrased to define a
numerator and denominator: the number of women in
whom a specific test or intervention has been performed,
divided by the number of women in whom this test or
intervention should have been performed. By this last step
use of the indicator can establish the percentage of adher-
ence when evaluating quality of care.
Results
The process of development of the indicators can be
seen in Figure 1.
Step 1
After selecting experts in one of the previously described
domains, a panel of thirteen members was assembled
consisting of five midwives (one of whom is first author),
seven obstetricians (including three of the authors) and an
ambulance paramedic. All midwives and obstetricians work
in maternity care and are actively involved in at least one of
the domains as described in the Methods section (Step 1).
Step 2
A literature search resulted in a list of publications
from which possible indicators could be extracted
[2-4,9,10,16-30]. From these publications, all possible
quality indicators for women at increased risk of PPH in
secondary care were collected. More than half of the indi-
cators were immediately discarded, as they are not applic-
able in primary midwifery care (e.g. surgical procedures
and embolisation). Two studies on PPH and homebirth in
an industrialised country were found. The authors made
recommendations on referral in case of PPH and/or
retained placenta after home birth [9,10]. These recom-
mendations were incorporated in the list of possible indi-
cators. This survey resulted in a list of 79 possible
indicators, which were categorized into five domains as
described in the ‘participants and methods’ section.
Step 3
A questionnaire composed of the 79 possible indicators
was sent to all panel members via email. The ambulanceparamedic only rated possible indicators within his field
of expertise and rated some indicators ‘not assessable’.
The expert panel proposed seven additional possible in-
dicators. Finally, a list of 86 possible indicators was pre-
pared for assessment at the consensus meeting.
Step 4
All panel members attended the meeting. After discussing
and reassessing the 86 possible indicators, 45 recommen-
dations were rated ‘valid’: four on prevention, nine on
500–1000 mL blood loss, 12 on >1000 mL blood loss, 14
on >2000 mL blood loss, and six on organization. The
remaining 41 indicators were rated ‘not valid’ and subse-
quently excluded (Figure 1).
Step 5
During critical evaluation by the core panel 18 potential
quality indicators were found to be overlapping and two
were discarded due to lack of measurability. Finally, a set of
25 potential indicators were transcribed into 25 quality in-
dicators for prevention and management of PPH in primary
midwifery care in the Netherlands (Table 1). The indicators
each now contain a numerator and denominator, i.e. in case
of PPH; the number of women with PPH who had an intra-
venous line is divided by the number of women with PPH.
Discussion
A RAND modified Delphi method approach was used to
develop a set of 25 quality indicators. This is the first set
of quality indicators concerning prevention and manage-
ment of PPH in primary midwifery care in the
Netherlands, to be used to assess care in case of PPH in
primary care. This is an essential contribution to the de-
velopment of guidelines of PPH in midwifery care.
The use of uterotonics, placing an intravenous line and
quick referral in all cases of PPH were considered of great
importance by the majority of the panel and thus incorpo-
rated in the final set. Possible indicators of the management
in case of PPH > 2000 mL were either accepted or rejected
with minimal dispersion. For some indicators however, as-
sessment of validity was a source of discussion. For ex-
ample, the routine use of oxytocin was hotly debated. As
shown in a nationwide survey, most obstetricians consider
this as part of standard care. In midwifery, though the use
of uterotonics has increased over the last decade, this is no
standard practice [30]. Currently, the Royal Dutch College
of Midwives has not issued a guideline for women at low-
risk of PPH or made any statement concerning manage-
ment of third stage of labour. Also, in Dutch midwifery
schools, no unambiguous policy is taught on the routine
use of uterotonics. In the process of guideline development
and implementation, routine use of uterotonics might be
an item for further discussion, especially also because of the
high prevalence of PPH in our country.
Table 1 Final set of quality indicators for the measurement of PPH-care in primary care
Median (n) Agreement (% of panellists
with score of 7, 8 or 9)
For prevention of PPH, the midwife should;
1 Antenatally: identify elevated- or high risk of PPH and agree on preventive strategies*.† 8.5 (12) 100
2 At birth: identify elevated- or high risk of PPH and agree (or adjust) preventive strategies*.† 8 (12) 100
3 If high risk of PPH is assessed: have birth occur in hospital supervised by the obstetrician. † 8.5 (12) 100
4 Routinely administer uterotonics (at least 5 IU oxytocin intramuscular). † 9 (12) 83,3
In case of blood loss >500 mL, without signs of shock the midwife should;
5 Measuring blood loss by weighing. † 9 (12) 91,6
6 Homebirth: in case of retained placenta; refer to secondary care after 30 minutes 9 (13) 92,3
7 Midwifery supervised hospital birth: in case of retained placenta; refer to secondary care after
30 minutes
9 (13) 75
8 Homebirth: if blood loss is not ceasing, refer to secondary care. † 9 (12) 83,4
9 Midwifery supervised hospital birth: if blood loss is not ceasing, refer to secondary care. † 9 (12) 83,3
10 Treat PPH as uterine atony (and apply bladder catheterization, uterine massage and oxytocin)
until proven otherwise.
9 (13) 100
11 Post placental: if blood loss is not ceasing despite administration of uterotonics, examine
for vaginal and perineal lesions. †
7 (12) 75
In case of PPH of >1000 mL and/or signs of shock, the midwife should;
12 Inform the secondary caregiver (obstetrician). 9 (13) 100
13 Start an intravenous line and supply with fluids, using 0, 9% sodium chloride. 8 (13) 100
14 Monitor vital signs frequently (pulse, blood pressure, respiratory frequency). 8 (13) 92,4
15 Regardless of oxygen saturation, provide patient with 10–15 litre oxygen via non-rebreathing
mask.
9 (13) 84,6
In case of PPH of > 1000 mL with signs of shock and/or >2000 mL blood loss the midwife
should;
16 In case of persisting haemorrhage with signs of shock, perform uterine and/ or aortal compression. † 8 (12) 83,3
17 Secure a second intravenous line (14 gauge). 9 (13) 79,9
18 If the patient has reduced consciousness due to hypovolemic shock, call for (paramedic)
assistance in order to establish an open airway.
9 (13) 83,4
19 Immediately transfer patient to secondary care. † (12) Added in
second round
100
Concerning cooperation and training;
20 Within every regional obstetric collaboration£ a regional PPH protocol should be present, based
on national guidelines.
9 (13) 91,7
21 A regional PPH protocol should be the basis of regular audits. 9 (13) 83,3
22 The midwife is aware that ambulance transportation in case of PPH or retained placenta is always
of the highest urgency category.
9 (13) 91,7
23 After each PPH with >2000 mL blood loss, the multidisciplinary team should debrief the situation. 8 (13) 83,4
24 Within the regional obstetric collaboration£ an annual training in obstetric emergencies should
be provided.
9 (13) 100
25 In a homebirth situation, anticipation on possible ambulance transport is necessary; make sure the
patient is at an accessible place for (all) caregivers in time.
9 (13) 100
* Preventative strategies imply consultation with an obstetrician to determine policy regarding PPH prevention e.g. birth supervised by obstetrician, or birth
supervised by midwife, but in hospital with intravenous access prior to birth.
£ Regional obstetric collaboration; a quarterly meeting with obstetricians and midwifery practices within a region in the Netherlands where policy, collaboration
and practical agreements are discussed.
† The ambulance paramedic did not rate these items; it was not within his field of expertise and stated these as ‘not assessable’.
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velopment initiatives has been proven, there are limita-
tions to this method [13,31,32]. Despite a thoroughliterature search, possible indicators may have been
overlooked. However, the expert panel was given ample
opportunity to propose additional items, both in the
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Of the seven additionally proposed indicators, three
were incorporated in the final set [32]. It is well-
documented that panel composition influences the out-
come of the indicator-development process [33]. If more
than one discipline of health care providers is included
in an expert panel, lower agreement in rating between
members are found, compared to when only expert in
one discipline make up the panel. In this study, the panel
consisted of a heterogenic group of professionals. There-
fore, in case of high agreement, that indicator can be con-
sidered highly valid. Furthermore, it has been shown that
the applied method (using a higher cut-off point for deter-
mining consensus with an overall median rate of 8 out of 9)
enhances the reproducibility of ratings if a different set of
panellists would rate the indicators [13].
In our literature search, many studies on PPH and
homebirth originated in low-resource countries [19,24,34].
However, home birth in these countries is rarely a well-
considered choice by women, and frequently being the re-
sult of poverty and lack of accessibility of health facilities.
Therefore, it was often impossible to extrapolate recom-
mendations into a western primary care setting. Only a
few studies contain relevant information on home birth
and referral in industrialised countries [9,35]. Thus, the
scientific evidence base was limited in this area of primary
care and necessitated the use of expert opinion in addition
to available evidence. Due to this finding, we conclude that
referral in case of PPH at home to hospital in indus-
trialised countries is under-researched.
All quality indicators need to be validated, in order to
ensure the clinical relevance [13,31]. Currently work is
underway to validate this set by assessing collected cases
of PPH in primary midwifery care in the Netherlands.
This set of indicators provides us with an instrument to
assess the care commencing in a primary midwifery set-
ting, before being transferred by ambulance to hospital.
Conclusion
A set of 25 quality indicators for prevention and manage-
ment of PPH in primary midwifery care in the Netherlands
was developed. This is the first set of quality indicators which
may serve as an assessment tool for prevention and manage-
ment of PPH in primary care. This is of great interest, as the
incidence of PPH is rising worldwide. Furthermore, existing
guidelines for secondary care can be combined with these
findings, so care throughout the care chain, including ambu-
lance referral, can be thoroughly evaluated.
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